Literatur

  • Adamkiewicz TV, Silk BJ, Howgate J et al: Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life. Pediatrics 2008; 121: 562-569
  • Adams RJ, McKie VC, Hsu L et al: Prevention of first stroke by transfusions in children with sickle cell anemia and abnormal results on trancranial doppler ultrasonography. N Engl J Med 1998; 339:5-11
  • Bernaudin F, Socie G, Kuentz M et al: Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood 2007; 110:2749-2756
  • Berthaut I, Guignedoux G, Kirsch-Noir F et al: Influence of sickle cell disease and treatment with hydroxyurea on sperm parameters and fertility of human males. haematologica 2008; 93:988-993
  • De Castro LM, Jonassaint JC, Graham FL, Ashley-Koch A, Telen MJ: Pulmonary hypertension associated with sickle cell disease: Clinical and laboratory endpoints and disease outcomes. Am J Hematol 2007; 83:19-25
  • Dickerhoff R: Sichelzellkrankheit in Deutschland. eine "exotische" Krankheit im medizinischen Alltag. Monatsschr Kinderheilkd 2006; 154:108101089
  • Dickerhoff R, von Rücker A, Maschmeyer G, Heimpel H: Probleme erwachsener Sichelzellpatienten in Deutschland . Dtsch Med  Wochenschr 2009; 134:1179-84
  • Dickerhoff R, von Rücker A: Schwangerschaft bei Sichelzellkrankheit. internist prax 2010; 50: 81-86
  • Fu T, Corrigan NJ, Quinn CT, Rogers ZR, Buchanan GR: Minor elective surgical procedures using general anesthesia in children with sickle cell anemia without pre-operative blood transfusion. Pediatr Blood Cancer 2005; 45:43-47
  • Gulbis B, Habermann D, Dufour D et al: Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events: the Belgian experience. Blood 2005;105:744-752
  • Hernigou P, Poignard A, Zilber S, Rouard H: Cell therapy of hip osteonecrosis with autologous bone marrow grafting. Indian J Orthop 2008; 43: 40-45
  • Islam MS, Anoop P: Current concepts in the management of stroke in children with sickle cell disease.Childs Nerv Syst 2011;27:1037-1043
  • Hsieh MM, Kang FM, Fitzhugh CD et al: Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. N Engl J med 2009; 361: 2309-2317
  • Maschmeyer G, Haas A, Dickerhoff R, Kleber FX: Pulmonale Hypertonie bei Sichelzellkrankheiten - Epidemiologie, Pathogenese, Diagnostik und Therapie. DMW 2007;132:103-107
  • Miller ST:How I treat acute chest syndrome in children with sickle cell disease.Blood 2011;117:5297-5305
  • Parent F, Bachir D, Inamo J et al: A Hemodynamic Study of Pulmonary Hypertension in Sickle Cell Disease. N Engl J Med 2011; 365:44-53
  • Ohene-Frempong K: Indications for red cell transfusion in sickle cell disease. Sem Hematol 2001; 38 (suppl 1) 5-13
  • Platt OS: Hydroxyurea for the treatment of sickle cell anemia. N Engl J Med 2008;358:1362-1369
  • Quinn CT, Rogers ZR, McCavit TL, Buchanan GR: Improved survival of children and adolescents with sickle cell disease. Blood 2010; 115:3447-3452
  • Rees DC, Olujohungbe AD, Parker NE et al: Guidelines for the management of the acute painful crisis in sickle cell disease. Br J Haematol 2003;120:744-752
  • Rombos Y, Tzanetea R, Kalotychou V et al: Amelioration of Painful Crises in Sickle Cell Disease by Venesections.Blood Cells, Molecules, and Diseases 2002;28:283-287
  • Serjeant G: Blood transfusion in sickle cell disease: a cautionary tale. Lancet 2003;361:1659-1660
  • Strouse JJ, Hulbert ML, DeBaun MR, Jordan LC, Dasella JF: Primary hemorrhagic stroke in children with sickle cell disease is assiciated with recent transfusion and use of corticosteroids. Pediatrics 2006;118:1916-1924
  • Stuart MJ, Nagel RL: Sickle cell disease. Lancet 2004;364:1343-1346
  • Styles LA, Vichinsky EP: Core decompression in avascular necrosis of the hip in sickle-cell disease. Am J Hematol. 1996; 52:103-107
  • Voskaridou E, Christoulas D, Bilalis A et al: The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS). Blood 2010; 115:2354-2363
  • Wykes C, Rees D: Expert reviews: The safety and efficacy of hydroxycarbamide in infants with sickle cell anemia. Expert Rev Hematol 2011; 4: 4070409
  • Zahed L, Bou-Dames J: Acceptance of first trimester prenatal diagnosis for the haemoglobinopathies in Lebanon. Prenat Diagn 1997; 17:423-428

Nach oben

MediathekInformation und Wissen
LageplanSo finden Sie uns